MAUDE Adverse Event Report: CORDIS US. CORP BRITE TIP RADIANZ; INTRODUCER, CATHETER

Catalog Number	687280110
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code	Obstruction/Occlusion (2422)
Date of Event	06/29/2023
Type of Reportable Event	Serious Injury
Event or Problem Description
As reported, one day after a procedure in which a 6f 110cm brite tip radianz catheter sheath introducer (csi) was used, there was an occlusion of the left radial artery which was related to the use of a 6f 110cm brite tip radianz csi.The occlusion reportedly resolved on its own four weeks after observation.No interventions were performed to treat the occlusion.This was during a radiancy study procedure in which vascular access was obtained in the left radial artery under duplex ultrasound guidance.5 ml¿s of heparin were given and an unknown 4f 100cm csi was inserted.An unknown guidewire was then inserted successfully across the target right common iliac artery lesion.The right iliac artery lesion was 30mm in length with a reference vessel diameter of 8mm.The lesion was a 100% stenosed de novo lesion with a minimum lumen diameter of 3mm.After insertion of the unknown guidewire, the unknown 4f 100cm csi was exchanged for a 6f 110 cm brite tip radianz csi which was successfully inserted into the peripheral vasculature through the radial artery.Next, pre-dilation of the lesion was performed with an 8mm x 3cm saberx radianz percutaneous transluminal angioplasty (pta) balloon catheter.The saberx radianz was inserted through the radial artery successfully and was inflated to 8 atmospheres (atm) with a 25% stenosis remaining post dilation.The saberx radianz pta balloon catheter was removed, and a 10mm x 30mm smart radianz self-expanding stent (ses) delivery system was then inserted through the radial artery.The stent was successfully deployed with 0% residual stenosis.The smart radianz ses delivery system was removed and an 8mm x 20mm smart radianz ses delivery system was inserted through the radial artery.The 8mm x 20cm smart radianz ses was successfully implanted with 0% residual stenosis and the delivery system was removed.An 8mm x 6cm saberx radianz pta balloon catheter was then inserted into the radial artery for post dilation of the lesion.The balloon was inflated to 8 atm with a residual stenosis of 0% and was removed.The brite tip radianz csi was removed, and a non-cordis vascular closure device was applied to the left radial artery for hemostasis.The device will not be returned for evaluation.
Additional Manufacturer Narrative
A review of the manufacturing documentation associated with lot 18079762 presented no issues during the manufacturing process that can be related to the reported event.Additional information is pending and will be submitted within 30 days upon receipt.H3 other text : device not available for return.
Event or Problem Description
As reported, one day after a procedure in which a 6f 110cm brite tip radianz catheter sheath introducer (csi) was used, there was an occlusion of the left radial artery which was related to the use of a 6f 110cm brite tip radianz csi.The occlusion reportedly resolved on its own four weeks after observation.No interventions were performed to treat the occlusion.Additionally, there was a small, grade i hematoma at the puncture site which was reported as mild in severity and had resolved on its own 28 days after observation.The hematoma was not related to any of the study devices; however, it was related to the procedure.This was during a radiancy study procedure in which vascular access was obtained in the left radial artery under duplex ultrasound guidance.5 ml¿s of heparin were given and an unknown 4f 100cm csi was inserted.An unknown guidewire was then inserted successfully across the target right common iliac artery lesion.The right iliac artery lesion was 30mm in length with a reference vessel diameter of 8mm.The lesion was a 100% stenosed de novo lesion with a minimum lumen diameter of 3mm.After insertion of the unknown guidewire, the unknown 4f 100cm csi was exchanged for a 6f 110 cm brite tip radianz csi which was successfully inserted into the peripheral vasculature through the radial artery.Next, pre-dilation of the lesion was performed with an 8mm x 3cm saberx radianz percutaneous transluminal angioplasty (pta) balloon catheter.The saberx radianz was inserted through the radial artery successfully and was inflated to 8 atmospheres (atm) with a 25% stenosis remaining post dilation.The saberx radianz pta balloon catheter was removed, and a 10mm x 30mm smart radianz self-expanding stent (ses) delivery system was then inserted through the radial artery.The stent was successfully deployed with 0% residual stenosis.The smart radianz ses delivery system was removed and an 8mm x 20mm smart radianz ses delivery system was inserted through the radial artery.The 8mm x 20cm smart radianz ses was successfully implanted with 0% residual stenosis and the delivery system was removed.An 8mm x 6cm saberx radianz pta balloon catheter was then inserted into the radial artery for post dilation of the lesion.The balloon was inflated to 8 atm with a residual stenosis of 0% and was removed.The brite tip radianz csi was removed, and a non-cordis vascular closure device was applied to the left radial artery for hemostasis.The device will not be returned for evaluation.
Additional Manufacturer Narrative
Additional information is pending and will be submitted within 30 days upon receipt.
Additional Manufacturer Narrative
Complaint conclusion: as reported, one day after a procedure in which a 6f 110cm brite tip radianz catheter sheath introducer (csi) was used, there was an occlusion of the left radial artery which was related to the use of a 6f 110cm brite tip radianz csi.The occlusion reportedly resolved on its own four weeks after observation.No interventions were performed to treat the occlusion.Additionally, there was a small, grade i hematoma at the puncture site which was reported as mild in severity and had resolved on its own 28 days after observation.The hematoma was not related to any of the study devices; however, it was related to the procedure.This was during a radiancy study procedure in which vascular access was obtained in the left radial artery under duplex ultrasound guidance.5 ml¿s of heparin were given and an unknown 4f 100cm csi was inserted.An unknown guidewire was then inserted successfully across the target right common iliac artery lesion.The right iliac artery lesion was 30mm in length with a reference vessel diameter of 8mm.The lesion was a 100% stenosed de novo lesion with a minimum lumen diameter of 3mm.After insertion of the unknown guidewire, the unknown 4f 100cm csi was exchanged for a 6f 110 cm brite tip radianz csi which was successfully inserted into the peripheral vasculature through the radial artery.Next, pre-dilation of the lesion was performed with an 8mm x 3cm saberx radianz percutaneous transluminal angioplasty (pta) balloon catheter.The saberx radianz was inserted through the radial artery successfully and was inflated to 8 atmospheres (atm) with a 25% stenosis remaining post dilation.The saberx radianz pta balloon catheter was removed, and a 10mm x 30mm smart radianz self-expanding stent (ses) delivery system was then inserted through the radial artery.The stent was successfully deployed with 0% residual stenosis.The smart radianz ses delivery system was removed and an 8mm x 20mm smart radianz ses delivery system was inserted through the radial artery.The 8mm x 20cm smart radianz ses was successfully implanted with 0% residual stenosis and the delivery system was removed.An 8mm x 6cm saberx radianz pta balloon catheter was then inserted into the radial artery for post dilation of the lesion.The balloon was inflated to 8 atm with a residual stenosis of 0% and was removed.The brite tip radianz csi was removed, and a non-cordis vascular closure device was applied to the left radial artery for hemostasis.The product was not returned for analysis.A product history record (phr) review of lot 18079762 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.Without the return of the device or images for analysis, the reported customer events ¿vascular occlusion¿ and ¿hematoma¿ could not be confirmed, and the underlying cause cannot be determined.Procedural factors or post procedure care may have contributed to the reported events.Additionally, vascular occlusion and hematoma are known complications and documented in the ifu as such.Users are trained to inspect for signs of damage prior to and during use.Any product with damage is not to be used.Information for safety is provided in the products labeling with the intent to make the user aware of the risks.According to the instructions for use (ifu), although not intended as a mitigation of risk, ¿prior to use, confirm that the catheter guiding sheath size is appropriate for the access vessel to be used.Possible complications include, but are not limited to: abrupt vessel closure, additional intervention, air embolism, allergic reaction (contrast medium and medications), embolic stroke/cerebral infarct, hematoma at puncture, hemorrhage, inflammation / infection / sepsis, intimal tear, ischemia, necrosis, pain, perforation of vessel wall, peripheral nerve injury, thrombus formation, vascular complications (e.G.Intimal tear, dissection, pseudo aneurysm, perforation, rupture, spasm, occlusion) based on the information available and the phr review, there is no indication that the event is related to the device design or manufacturing process.Therefore, no preventative or corrective actions will be taken at this time.
Event or Problem Description
As reported, one day after a procedure in which a 6f 110cm brite tip radianz catheter sheath introducer (csi) was used, there was an occlusion of the left radial artery which was related to the use of a 6f 110cm brite tip radianz csi.The occlusion reportedly resolved on its own four weeks after observation.No interventions were performed to treat the occlusion.Additionally, there was a small, grade i hematoma at the puncture site which was reported as mild in severity and had resolved on its own 28 days after observation.The hematoma was not related to any of the study devices; however, it was related to the procedure.This was during a radiancy study procedure in which vascular access was obtained in the left radial artery under duplex ultrasound guidance.5 ml¿s of heparin were given and an unknown 4f 100cm csi was inserted.An unknown guidewire was then inserted successfully across the target right common iliac artery lesion.The right iliac artery lesion was 30mm in length with a reference vessel diameter of 8mm.The lesion was a 100% stenosed de novo lesion with a minimum lumen diameter of 3mm.After insertion of the unknown guidewire, the unknown 4f 100cm csi was exchanged for a 6f 110 cm brite tip radianz csi which was successfully inserted into the peripheral vasculature through the radial artery.Next, pre-dilation of the lesion was performed with an 8mm x 3cm saberx radianz percutaneous transluminal angioplasty (pta) balloon catheter.The saberx radianz was inserted through the radial artery successfully and was inflated to 8 atmospheres (atm) with a 25% stenosis remaining post dilation.The saberx radianz pta balloon catheter was removed, and a 10mm x 30mm smart radianz self-expanding stent (ses) delivery system was then inserted through the radial artery.The stent was successfully deployed with 0% residual stenosis.The smart radianz ses delivery system was removed and an 8mm x 20mm smart radianz ses delivery system was inserted through the radial artery.The 8mm x 20cm smart radianz ses was successfully implanted with 0% residual stenosis and the delivery system was removed.An 8mm x 6cm saberx radianz pta balloon catheter was then inserted into the radial artery for post dilation of the lesion.The balloon was inflated to 8 atm with a residual stenosis of 0% and was removed.The brite tip radianz csi was removed, and a non-cordis vascular closure device was applied to the left radial artery for hemostasis.The device will not be returned for evaluation.

• Brand Name: BRITE TIP RADIANZ
• Common Device Name: INTRODUCER, CATHETER
• Manufacturer (Section D): CORDIS US. CORP; 14201 nw 60 avenue; miami lakes, florida 33014
• Manufacturer (Section G): CORDIS US CORP.; 14201 nw 60 avenue; miami lakes FL 33014
• Manufacturer Contact: karla castro ; santiago troncoso 808; juarez, chihuahua ; 7863138372
• MDR Report Key: 17740847
• Report Number: 9616099-2023-06595
• Device Sequence Number: 17795919
• Product Code: DYB
• UDI-Device Identifier: 20705032081228
• UDI-Public: (01)20705032081228(17)231231(10)18079762
• Combination Product (Y/N): N
• Initial Reporter Country: US
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Foreign,Study,Health Professional,Company Representative
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 12/08/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Expiration Date: 12/31/2024
• Device Catalogue Number: 687280110
• Device Lot Number: 18079762
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 08/23/2023
• Supplement Date Received by Manufacturer: 09/21/2023; 12/06/2023
• Initial Report FDA Received Date: 09/13/2023
• Supplement Report FDA Received Date: 10/16/2023; 12/08/2023
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 01/25/2022
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: SABERX RADIANZ 8MM4CM 190; SABERX RADIANZ 8MM6CM 190; SMART RADIANZ 10X20 150CM; TERUMO VASCULAR CLOSURE DEVICE; UNKNOWN SHEATH 100MM 4FR
• Outcome Attributed to Adverse Event: Other
• Patient Age: 71 YR
• Patient Sex: Male
• Patient Weight: 90 KG